scholarly article | Q13442814 |
P50 | author | David T. Curiel | Q64384545 |
P2093 | author name string | G Yancey Gillespie | |
Donald J Buchsbaum | |||
Sergey A Kaliberov | |||
Mark Carpenter | |||
Murray A Stackhouse | |||
Waleed O Arafat | |||
P433 | issue | 2 | |
P921 | main subject | endothelium | Q111140 |
Adenoviridae | Q193447 | ||
P304 | page(s) | 190-198 | |
P577 | publication date | 2002-08-01 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells | |
P478 | volume | 6 |
Q40488102 | Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer |
Q39491365 | Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo. |
Q45858863 | An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma |
Q36226789 | Cancer-specific gene therapy. |
Q38047477 | Chapter seven--Cancer treatment with gene therapy and radiation therapy |
Q45880240 | Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. |
Q40462233 | Effect of hypoxia on Ad5 infection, transgene expression and replication. |
Q40587921 | Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. |
Q41925534 | Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy |
Q40357610 | Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells. |
Q40311561 | Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs |
Q38737078 | TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells |
Q36387929 | Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application |
Search more.